Christina Isacson is a Partner at Lightstone Ventures focusing on biopharmaceutical investments. She has experience in venture capital and operational roles within the biotechnology industry.

What Christina can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BLead preference not reported
Best routeA warm introAsk a founder in their portfolio.

Career

  1. Boston University’s Technology Development Fund
  2. Accelerator Corp (Fund I)
  3. Ironwood Pharmaceuticals (NASDAQ:IRWD)
  4. Third Rock Ventures · Principal
  5. Magenta Therapeutics (NASDAQ:MGTA) · Chief Business Officer
  6. Lightstone Ventures · Partner
    Now

Companies founded

Magenta TherapeuticsDecibel Therapeutics

Investments named in public bios

Magenta Therapeutics (NASDAQ:MGTA)Decibel Therapeutics (NASDAQ:DBTX)

Focus

biopharmaceutical

Education

McGill University, B.Sc. BiologyTufts University School of Medicine, Graduate School of Biomedical Sciences, Ph.D. Neuroscience

Also at Lightstone Ventures

Partners like Christina

At firms with a similar stage, sector and check size.

Alert me when Lightstone Ventures is active

One email when Christina's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Christina Isacson?

Christina Isacson is a Partner at Lightstone Ventures focusing on biopharmaceutical investments. She has experience in venture capital and operational roles within the biotechnology industry.

How much does Christina Isacson invest?

Lightstone Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Christina Isacson?

A warm intro from a founder Lightstone Ventures backed works best.

What did Christina Isacson do before Lightstone Ventures?

Boston University’s Technology Development Fund; Accelerator Corp (Fund I); Ironwood Pharmaceuticals (NASDAQ:IRWD); Principal at Third Rock Ventures; Chief Business Officer at Magenta Therapeutics (NASDAQ:MGTA).

Last updated 2026-10-15. Is this you? Ask for a correction.